From Nasdaq: 2025-04-25 12:27:00

New analyst forecast for $NVDA by UBS rates it as ‘Buy’. 20 firms issued buy ratings on $NVDA, with no sell ratings in the last few months. Analysts like Piper Sandler, Wedbush, Raymond James, Citigroup, and others have recently issued positive ratings for $NVDA.

Multiple analysts have set price targets for $NVDA, with a median target of $175. Recent targets by analysts like Raymond James, Needham, KeyBanc, Morgan Stanley, Stifel Nicolaus, and HSBC, among others, indicate positive expectations for $NVDA’s stock performance.

Members of Congress have traded $NVDA stock 44 times in the past 6 months, with 20 purchases and 24 sales. Notable trades by representatives like Marjorie Taylor Greene, Dwight Evans, and others reflect active trading of $NVDA stock by politicians.

Insiders have traded $NVDA stock 34 times in the past 6 months, with 0 purchases and 34 sales. Executives like Colette Kress, Ajay K Puri, and others have sold significant amounts of $NVDA shares, indicating insider sentiment towards the stock.

Institutional investors have made significant moves with $NVDA stock, with 2,385 adding shares and 2,107 reducing positions in the last quarter. Notable changes by institutions like Bank of America, Legal & General Group PLC, BlackRock, and others reflect shifting sentiments towards $NVDA’s stock.



Read more at Nasdaq: New Analyst Forecast: $NVDA Given ‘Buy’ Rating